Ovarian Cancer Drugs Market Research Reports

Drug Overview: Lynparza - Product Thumbnail Image

Drug Overview: Lynparza

  • Drug Pipelines
  • 61 Pages
From
Drug Overview: Rubraca - Product Thumbnail Image

Drug Overview: Rubraca

  • Drug Pipelines
  • 29 Pages
From
Ovarian Cancer - Heat Map and Analysis - Product Thumbnail Image

Ovarian Cancer - Heat Map and Analysis

  • Drug Pipelines
  • 16 Pages
From
Loading Indicator

Far less common than breast cancer, but with a higher mortality rate, sufferers of ovarian cancer are experiencing significant unmet needs. There are therefore considerable market opportunities for drug designers and manufacturers in this life-saving sector of the pharmaceutical industry. In this section a host of cutting edge reports provide valuable insight into key markets such as China and the US, the latest drug development activities and the market trends (including sales, pricing and forecasts) for specific drugs like Doxil, Caelyx, Yondelis and Paclitaxel. You can also purchase reports that feature the latest strategies of major and niche industry players such as Alza Corporation, Amgen, Bristol-Myers Squibb, Cell Therapeutics, Genentech, GlaxoSmithKline, Immunogen, Ivax, OSI Pharmaceuticals and Raven Biotechnologies.
Show Less
Read more

adroll